Mutation in the sterol 27-hydroxylase gene associated with fatal cholestasis in infancy

Sara von Bahr1, Ingemar Björkhem, Ferdinand Van't Hooft

  • 1Department of Clinical Chemistry, Huddinge University Hospital, Karolinska Institutet, Stockholm, Sweden.

Insights

Cerebrotendinous xanthomatosis (CTX), a rare inborn error of bile acid synthesis, can cause neonatal cholestasis. Early diagnosis via urinary steroid analysis is crucial for timely bile acid treatment.

Area of Science:

  • Biochemistry
  • Genetics
  • Pediatrics

Background:

  • Inborn errors of bile acid synthesis are rare causes of neonatal cholestasis.
  • Neonatal cholestasis can be a treatable condition if diagnosed early.

Observation:

  • A cholestatic infant with cytomegalovirus infection presented with severe liver disease.
  • Urinary analysis revealed glucuronidated bile alcohols, indicative of cerebrotendinous xanthomatosis (CTX).
  • Plasma oxysterol analysis showed reduced 27-hydroxycholesterol levels.

Findings:

  • Genetic analysis confirmed a mutation in the sterol 27-hydroxylase gene, diagnosing CTX.
  • This is the first reported case of CTX diagnosed in Sweden.
  • Reduced sterol 27-hydroxylase activity may predispose infants to neonatal cholestasis.

Implications:

  • Early diagnosis of CTX is essential for initiating bile acid treatment.
  • Urinary steroid analysis using electrospray mass spectrometry is recommended for neonatal cholestasis investigations.
  • CTX should be considered in cases of neonatal cholestasis, especially with a history of sibling mortality.
Abstract

Related Concept Videos

Lethal Alleles02:41

Lethal Alleles

Agouti: A Lethal Allele
Lucien Cuénot discovered lethal alleles in 1905 while studying the inheritance of coat color in mice. The agouti gene is responsible for the color of the coat in mice. This gene codes for an agouti-signaling protein, which is responsible for melanin distribution in mammals. The wild-type allele gives rise to gray-brown coat color in mice, while the mutant allele gives rise to yellow coat color. In addition to coat color, the agouti gene is associated with the yellow...
Jaundice01:25

Jaundice

Jaundice, or icterus, is the yellow discoloration of the skin, sclerae, and mucous membranes. It happens when plasma bilirubin levels rise above 2.5-3 mg/dL, leading to bilirubin deposition in tissue.Bilirubin is a byproduct of hemoglobin degradation. In macrophages, hemoglobin breaks down into globin and heme. Globin is converted into amino acids, while heme is turned into biliverdin by heme oxygenase, which is then reduced to unconjugated bilirubin by biliverdin reductase.Unconjugated...
Alternative RNA Splicing02:18

Alternative RNA Splicing

Alternative RNA splicing is the regulated splicing of exons and introns to produce different mature mRNAs from a single pre-mRNA. Unlike in constitutive splicing where a single gene produces a single type of mRNA, alternative splicing allows an organism to produce multiple proteins from a single gene and plays an important role in protein diversity.
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
Mutations01:39

Mutations

Overview